Efficacy from the Phase 1 Study of FID-007, a Novel Nanoparticle Paclitaxel Formulation, in Patients with Head and Neck Squamous Cell Carcinoma.
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Clinical Oncology(2024)